Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.

Source:http://linkedlifedata.com/resource/pubmed/id/11714771

J. Immunol. 2001 Dec 1 167 11 6123-31

Download in:

View as

General Info

PMID
11714771